Pre-clinical markers for diagnosis of diabetic nephropathy in patients with type 1 diabetes mellitus

被引:0
作者
Lebedeva, N. O. [1 ]
Vikulova, O. K. [1 ]
机构
[1] Endocrinol Res Ctr, Moscow, Russia
来源
DIABETES MELLITUS | 2012年 / 15卷 / 02期
关键词
diabetic nephropathy; diabetes mellitus type 1; pre-clinical diagnostics; proteomic analysis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Due to progressive nature of diabetic nephropathy (DN) and limited effectiveness of therapeutic efforts at clinically overt stages, diagnosis of pre-clinical (and, therefore, potentially reversible) DN is especially important. To date, however, test for microalbuminuria remains the only technique applicable for early diagnostics of DN. Current review addresses search for potential markers of pre-clinical stage of DN in patients with type 1 diabetes mellitus and embraces data from latest experimental and clinical studies in this area.
引用
收藏
页码:38 / 45
页数:8
相关论文
共 50 条
  • [21] Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy
    Noor, Tooba
    Hanif, Farina
    Kiran, Zareen
    Rehman, Rehana
    Khan, Muhammad Tassaduq
    Haque, Zeba
    Nankani, Kelash
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (06) : 548 - 555
  • [22] The role of coagulation and inflammation in the development of diabetic nephropathy in patients with diabetes mellitus type 2
    Khasanova, Yu. V.
    Nelayeva, A. A.
    Galkina, A. B.
    Medvedeva, I. V.
    DIABETES MELLITUS, 2012, 15 (01): : 31 - 34
  • [23] Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus
    Hu, Fan
    Zhang, Taotao
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 351 - 360
  • [24] The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
    Bherwani, Sonny
    Saumya, A. S.
    Ahirwar, Ashok Kumar
    Sandhya, A. S.
    Prajapat, Brijesh
    Patel, Sitendu
    Singh, Ritu
    Ghotekar, L. H.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2016, 16 (02) : 120 - 123
  • [25] Prevalence of NAFLD and Its Correlation with Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
    Kaur, Simran
    Laxmareddygari, Sushma
    Gupta, Nitin
    Tabjula, Akshith Rajgupta
    Joshi, Yavatesh
    Dhaliwal, Sargam
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2021, 10 (11): : 809 - 812
  • [26] Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
    Song, Ki-Ho
    Jeong, Jee-Sun
    Kim, Mee Kyoung
    Kwon, Hyuk-Sang
    Baek, Ki-Hyun
    Ko, Seung-Hyun
    Ahn, Yu-Bae
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 745 - 752
  • [27] ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy
    Sulaj, Alba
    Kopf, Stefan
    Grone, Elisabeth
    Grone, Hermann-Josef
    Hoffmann, Sigrid
    Schleicher, Erwin
    Haring, Hans-Ulrich
    Schwenger, Vedat
    Herzig, Stephan
    Fleming, Thomas
    Nawroth, Peter P.
    von Bauer, Rudiger
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (06) : 1058 - 1065
  • [28] Does dietary protein intake correlate with markers suggestive of early diabetic nephropathy in children and adolescents with Type 1 diabetes mellitus?
    O'Hayon, BE
    Cummings, EA
    Daneman, D
    Ossip, MG
    Lawson, ML
    Sochett, EB
    DIABETIC MEDICINE, 2000, 17 (10) : 708 - 712
  • [29] Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus
    Moczulski, DK
    Scott, L
    Antonellis, A
    Rogus, JJ
    Rich, SS
    Warram, JH
    Krolewski, AS
    DIABETIC MEDICINE, 2000, 17 (02) : 111 - 118
  • [30] Polymorphism of the angiotensinogen gene and genetic predisposition to diabetic nephropathy in diabetes mellitus type 1
    Chistyakov, DA
    Turakulov, RI
    Kondrat'ev, YY
    Shestakova, MV
    Nosikov, VV
    Dedov, II
    Debabov, VG
    MOLECULAR BIOLOGY, 1999, 33 (02) : 177 - 179